Effects of a novel cholinergic ion channel agonist SIB-1765F on locomotor activity in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 1, 1997, Pages 384-392

  Menzaghi, Frédérique ^a   Whelan, Kevin T ^a   Risbrough, Victoria B ^a   Rao, Tadimeti S ^a   Kenneth Lloyd, G ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 ETHYNYL 5 (1 METHYL 2 PYRROLIDINYL)PYRIDINE FUMARATE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; DIHYDRO BETA ERYTHROIDINE; EPIBATIDINE; ETICLOPRIDE; HEXAMETHONIUM; MECAMYLAMINE; NICOTINE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG EFFECT; LOCOMOTION; MALE; MOTOR ACTIVITY; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ION CHANNELS; MALE; MOTOR ACTIVITY; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PYRIDINES; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; SALICYLAMIDES;

EID: 0030999767     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. ARNOLD, B., ALLISON, K., IVANOVA, S., PAETSCH, P. R., PASLAWSKI, T. AND GREENSHAW, A. J.: 5HT3 receptor antagonists do not block nicotine induced hyperactivity in rats. Psychcpharmacology 119: 213-221, 1995.
2. BENWELL, M. E. M. AND BALFOUR, D. J. K.: The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br. J. Pharmacol. 105: 849-856, 1992.
3. CLARKE, P. B. S. AND KUMAR. R.: Effects of nicotine on locomotor activity in non-tolerant and tolerant rats. Br. J. Pharmacol. 78: 329-37, 1983.
4. 3H]-dopamine release. Br. J. Pharmacol. 117: 595-606, 1996.
5. COSFORD, N. D. P., BLEICHER, L., HERRAUT, A., McC. A. L.L. U. M. S., VERNIER, J-M., DAWSON, H., WHITTEN, J. P., ADAMS, P., CHAVEZ-NORIEGA. L., CORREA, L. D., CRONA, J. H., MAHAFFY, L. S., MENZAGHI, F., RAO, T. S., REID, R. T., SACAAN, A. I., SANTORI, E. M., STAUDERMAN, K. A., WHELAN, K. D., LLOYD, G. K. AND McDoNALD, I. A.: (S)-(-)-5-Ethyny]-3-(1-methyl-2-pyrrolidinyl)pyridine maleate (S. I. B.-1508Y): A novel antiparkinsonian agent with selectivity for neuronal nicotinic acetylcholine receptors. J. Med. Chem. 39: 3235-3237, 1996.
6. DAMAJ, M. I., WELCH. S. P. AND MARTIN, B. R.: In vivo pharmacological effects of dihydro-β-erythroidine, a nicotinic antagonist, in mice. Psychopharmacology 117: 67-73, 1995.
7. DAMSMA. O., WESTERINK, B. H. C., D. E. VRIES, J. B. AND HORN, A. S.: The effect of systemically applied cholinergic drugs on the striatal release of dopamine and its metabolites, as determined by automated brain dialysis in conscious rats. Neurosci. Lett. 89: 349-354, 1988.
8. DAMSMA, G., DAY, J. AND FIBIGER, H. C.: Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens. Eur. J. Pharmacol. 168: 363-368, 1989.
9. GARCHA, H. S., THOMAS, P., SPIVAK, C. E., WONNACOTT, S. AND STOLERMAN, I. P.: Behavioural and ligand-binding studies in rats with 1-acetyl-4-methylpiperazine, a novel nicotinic agonist. Psychopharmacology 110: 347-354, 1993.
10. IMPERATO, A., MULAS, A. AND D. I. CHIARA, G.: Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur. J. Pharmacol. 132: 337-339, 1986.
11. KSIR, C. J., HAKAN, R. L. AND KELLAR, K. J.: Chronic nicotine and locomotor activity: Influences of exposure dose and test dose. Psychopharmacology 92: 25-29, 1987.
12. LEIKOLA-PELHO, T. AND JACKSON, D. M.: Preferential stimulation of locomotor activity by ventral tegmental microinjactions of (-)-nicotine. Pharmacol. Toxicol. 70: 50-52, 1992.
13. LLOYD. G. K., RAO, T. S., SACAAN, A., REID, R., CORREA, L. D., WHELAN, K., RISBROUGH, V. AND MENZAGHI, F.: SIB-1765F, a novel nicotinic agonist: Profile in models of extrapyramidal motor dysfunction. Soc. Neurosc. Abst. 21: 11.10, 1995.
14. MARTIN. B. R., MARTIN. T. F., FAN, F., DAMAJ, M. I.: Central actions of nicotine antagonists. Med. Chem. Res. 2: 564-577, 1993.
15. MENZAGHI, F., WHELAN, K. T., REID, R., SACAAN, A. I., RISBROUGH, V. B., RAO, T. S. AND LLOYD, G. K.: SIB-1765F: A novel nicotinic agonist with locomotor stimulant properties in rats. Soc. Neurosci. Abst. 21: 247.5, 1995.
16. MIRZA, N. R., PEI, Q., STOLERMAN, I. P. AND ZETTERSTROM, T. S. C.: The nicotinic receptor agonists (-)-nicotine and isoarecolone differ in their effects on dopamine release in the nucleus accumbens. Eur. J. Pharm. 295: 207-210 1996.
17. MORRISON, C. F. AND STEPHENSON, J. A.: The occurrence of tolerance to a central depressant effect of nicotine. Br. J. Pharmacol. 46: 151-156, 1972.
18. MUSEO, E. AND WISE, R. A.: Microinjections of a nicotinic agonist into dopamine terminal fields: Effects on locomotion. Pharmacol. Biochem. Behav. 37: 113-116, 1990.
19. O'NEILL, M. F., DOURISH, C. T. AND IVERSEN, S. D.: Evidence for an involvement of D1 and D2 dopamine receptors in mediating nicotine-induced hyperactivity in rats. Psychopharmacology 104: 343-50, 1991.
20. PATRICK, J. W. AND LUETJE, C. W.: Pharmacological diversity of nicotine receptors. In Biological Basis for Substance Abuse, ed. by S. G. Korenman and J. D. Barchas, pp. 81-94. Oxford University Press, New York, 1993.
21. RAO, T. S., SACAAN, A. I., REID, R., CORREA, L., ADAMS, P., BLEICHER, L., COSFORD, N., McDONALD, I. AND LLOYD, G. K.: In vitro characterization of SIB-1765F, a novel nicotinic agonist. Soc. Neurosci. Abs. 21: 247.4, 1995.
22. 3H] (-)-nicotine to rat brain membranes and its inhibition by analogues of nicotine. Neuropharmacology 27: 235-241, 1988.
23. REAVILL, C. AND STOLERMAN, I. P.: Locomotor activity in rata after administration of nicotinic agonists intracerebrally. Br. J. Pharmacol. 99: 273-278. 1990.
24. REAVILL, C., WATERS, J. A., STOLERMAN, I. P. AND GARCHA, H. S.: Behavioural effects of the nicotinic agonists N-(3-pyridylmethyl)pyrrolidine and isoarecolone in rats. Psychopharmacology 102: 521-528, 1990.
25. RICHARDSON, S. A. AND TIZABI, Y.: Hyperactivity in the offspring of nicotine-treated rats: Role of the mesolimbic and nigrostriatal dopaminergic pathways. Pharmacol. Biochem. and Behavior 47: 331-337, 1994.
26. SACAAN, A. I., DUNLOP, J. L. AND LLOYD, G. K.: Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. J. Pharm. Exp. Ther. 274: 224-230, 1995.
27. SACAAN, A. I., MENZAGHI, F., DUNLOP, J. L., CORREA, L. D., WHELAN, K. T. AND LLOYD, G. K.: Epibatidine: A nicotinic acetylcholine receptor agonist releases monoaminergic neurotransmitters. In vitro and in vivo evidence in rats. J. Pharmacol. Exp. Ther. 276: 509-515, 1996.
28. STOLERMAN, I. P., FINK, R. AND JARVIK, M. E.: Acute and chronic tolerance to nicotine measured by activity in rats. Psychopharmacologia 30: 329-342, 1973.
29. STOLERMAAN, I. P., BUNKER, P. AND JARVIK, M. E.: Nicotine tolerance in rats: Role of dose and dose interval. Psychopharmacologia 34: 317-324, 1974.
30. STOLERMAM, I. P., ALBUQUERQUE, E. X. AND GARCHA, H. S.: Behavioural effects of anatoxin, a potent nicotinic agonist, in rats. Neuropharmacology 31: 311-314, 1992.
31. STOLERMAN, I. P., GARCHA, H. S. AND MIRZA, N. R.: Dissociations between the locomotor stimulant and depressant effects of nicotinic agonists in rats. Psychopharmacology 117: 430-437, 1995.
32. VALERA, S., BALLIVET, M. AND BERTRAND, D.: Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A. 89: 9949-9953, 1992.
33. VARANDA, W. A., ARACAVA, Y., SHERBY, S. M., VAN METER R. W. G., ELDEFRAWI, M. E. AND ALBUQUERQUE, E. X.: The ACh receptor of the neuromuscular junction recognizes mecamylamine as a noncompetitive antagonist. Mol. Pharmacol. 28: 125-137, 1985.
34. WELZL, H., BATTIG, K. AND BERZ, S.: Acute effects of nicotine injection into the nucleus accumbens on locomotor activity in nicotine-naive and nicotine tolerant rats. Pharmacol., Biochem. Behav. 37: 743-746, 1990.
35. WHITEAKER, P., GARCHA, H. S., WONNACOTT, S. AND STOLERMAN, I. P.: Locomotor activation and dopamine release produced by nicotine and isoarecolone in rats. Br. J. Pharmacol. 116: 2097-2105, 1995.
36. WILLIAMS, M. AND ROBINSON, J. L.: Binding of the nicotinic cholinergic antagonists, dihydro-β-erythroidine, to rat brain tissues. J. Neurosci. 4: 2906-2911, 1984.